Explore: Biotech · Seed · United Kingdom
Imperagen
seed · 🇬🇧 Manchester, United Kingdom · Founded 2021
Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly. Imperagen is a biotech and deeptech startup based in Manchester, United Kingdom, founded 2021, at seed stage, with $6.7M raised to date.
Imperagen is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.
Total raised
$6.7M
Stage
seed
Business model
SaaS
Target customer
Pharmaceutical manufacturers, life sciences companies, and industrial/fine chemical companies needing custom enzyme optimization and development
Sectors
biotechdeeptechhealthtechSaaSautomation
Key investors
IQ Capital, Northern Gritstone
Backed by
Team enrichment — names, roles, LinkedIn, X and email where availableSign in to view
Frequently asked questions
- What does Imperagen do?
- Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.
- Where is Imperagen based?
- Imperagen is based in Manchester, United Kingdom, founded in 2021.
- How much has Imperagen raised?
- Imperagen has raised $6.7M in tracked funding and is currently at the seed stage.
- Who has invested in Imperagen?
- Investors in Imperagen include IQ Capital and Northern Gritstone.